USA's CDC awards $16.9M contract to ATCC
The US Centers for Disease Control and Prevention (CDC) has awarded a $16.9 million contract to American Type Culture Collection of Manassas, Virginia, to implement the agency's Influenza Reagent Resource (CDC-IRR), a secure, web-based system that will improve access to influenza viruses, test kits and other reagents for approved laboratories. The contract with ATCC is for one year, with the option to renew each year for up to 10 years.
"This new resource will be a significant improvement for accessing the CDC library of influenza viruses," said Nancy Cox, Director of the Influenza Division at the CDC, adding: "we expect that the CDC-IRR will speed the development of better diagnostic tests, antiviral drugs and vaccines."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze